Molecular Diagnostics Platform Providers Receive Support from New England Biolabs' NEBsolutions® Team
IPSWICH, Mass., July 25, 2013 /PRNewswire/ -- NEBsolutions, a dedicated team of customized reagent and service specialists at New England Biolabs® (NEB), is pleased to offer a suite of reagents and capabilities for molecular diagnostics (MDx) product development, at this year's Annual Meeting of the American Association of Clinical Chemistry (AACC).
(Logo: http://photos.prnewswire.com/prnh/20130725/NE52724LOGO )
NEB, a leader in the development and production of reagents for the life science industry, provides reagents for a variety of MDx applications, such as sample preparation, PCR, RT-PCR, isothermal amplification, methylation detection, and library preparation for next generation sequencing. By working with the NEBsolutions team, providers gain access to NEB's high-quality reagents, in addition to direct access to enzymology expertise, supply logistics, custom formulations, packaging, and kit development capabilities.
"NEB has been supplying high-quality reagents to the molecular diagnostics community since 1995," says John Pelletier, Director of NEBsolutions at NEB. "Through the NEBsolutions team, you gain access to NEB's broad array of resources, including the deep scientific know-how to functionally optimize your product, comprehensive experience in the manufacturing of high-quality products, and extensive experience in supply chain management and risk mitigation. Our quality-by-design approach ensures product performance and consistency that surpass customer needs."
The 2013 AACC meeting takes place July 28th through August 1st, 2013 in Houston, TX. The NEBsolutions team can be found at AACC booth 4463. To enable you to discuss all of your reagent requirements, members of NEB's Quality, Polymerase Development, and Business Development teams will also be available at the booth. To learn what NEBsolutions can do for you, contact [email protected] or visit www.neb.com/neb-solutions.
NEBSOLUTIONS® and NEW ENGLAND BIOLABS® are registered trademarks of New England Biolabs, Inc.
About New England Biolabs
Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, library preparation for next generation sequencing, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com.
SOURCE New England Biolabs
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article